“FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON: Pidotimod: Revisiting a Classic Immunomodulator”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025057, Aug. 2025, doi: 10.4084/MJHID.2025.057.